Tahoe Therapeutics
Tahoe Therapeutics develops AI-powered tools to simulate human cell responses and guide drug discovery. It operates a platform called Mosaic that produces large-scale single-cell datasets detailing how drug molecules interact with diverse patient cells, with initial applications in oncology. It open-sources its Tahoe-100M dataset, comprising hundreds of millions of single-cell profiles, to train AI models that build virtual cell models for therapeutic insights. A recent funding round enabled the creation of an even larger dataset, targeting one billion cell datapoints and one million drug-patient interactions, designed to fuel next-generation precision medicines
Domain
tahoebio.ai
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$30.0M
Founded
2021
Tech Stack (13 technologies)
Frequently Asked Questions
What technologies does Tahoe Therapeutics use?+
Tahoe Therapeutics uses 13 technologies including Google Font API, Three.js, Webflow.
What industry is Tahoe Therapeutics in?+
Tahoe Therapeutics operates in the Artificial Intelligence (AI) industry.
Where is Tahoe Therapeutics based?+
Tahoe Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026